Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer

被引:144
作者
Seppenwoolde, Y [1 ]
De Jaeger, K [1 ]
Boersma, LJ [1 ]
Belderbos, JSA [1 ]
Lebesque, JV [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, NL-1066 CX Amsterdam, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 03期
关键词
radiation pneumonitis; NTCP; lung cancer; radiotherapy;
D O I
10.1016/j.ijrobp.2004.04.037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study regional differences in lung radiosensitivity by evaluating the incidence of radiation pneumonitis (RP) in relation to regional dose distributions. Methods and Materials: Registered chest CT and single photon emission CT lung perfusion scans were obtained in 106 patients before curative or radical radiotherapy for non-small-cell lung cancer. The mean lung dose (MLD) was calculated. The single photon-emission CT perfusion data were used to weigh the MLD with perfusion, resulting in the mean perfusion-weighted lung dose. In addition, the lungs were geometrically divided into different subvolumes. The mean regional dose (MRD) for each region was calculated and weighted with the perfusion of each region to obtain the mean perfusion-weighted regional dose. RP was defined as respiratory symptoms requiring steroids. The incidence of RP for patients with tumors in a specific subvolume was calculated. The normal tissue complication probability (NTCP) parameter values for the TD50, and an offset NTCP parameter for tumor location were fitted for both lungs and for each lung subvolume to the observed data using maximum likelihood analysis. Results: The incidence of RP correlated significantly with the MLD and MRD of the posterior, caudal, ipsilateral, central, and peripheral lung subvolumes (p between 0.05 and 0.002); no correlation was seen for the anterior, cranial, and contralateral regions Similarly, a statistically significant correlation was observed between the incidence of RP and the perfusion-weighted MLD and perfusion-weighted MRD for all regions, except the anterior lung region. For this region, the dose-effect relation improved remarkably after weighting the local dose with the local perfusion. A statistically significant difference (p = 0.01) in the incidence of RP was found between patients with cranial and caudal tumors (11% and 40%, respectively). Therefore, a dose-independent offset NTCP parameter for caudal tumors was included in the NTCP model, improving most correlations significantly, confirming that patients with caudal tumors have a greater probability of developing RP. Conclusion: The incidence of RP correlated significantly with the MLD and MRD of most lung regions, except for the anterior, cranial, and contralateral regions. Weighting the local dose with the local perfusion improved the dose-effect relation for the anterior lung region. Irradiation of caudally located lung tumors resulted in a greater risk of RP than irradiation of tumors located in other parts of the lungs. (C) 2004 Elsevier Inc.
引用
收藏
页码:748 / 758
页数:11
相关论文
共 50 条
  • [21] Concomitant radiochemotherapy of advanced non-small-cell lung cancer
    Fietkau, R
    LUNG CANCER, 2001, 33 : S65 - S76
  • [22] Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
    Chen, Lanyi Nora
    Wei, Alexander Z.
    Shu, Catherine A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [23] ADVANCES IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER
    SCULIER, JP
    PATHOLOGIE BIOLOGIE, 1991, 39 (09): : 938 - 939
  • [24] Asbcopal Effects after Conventional and Stereotactic Lung Irradiation of Non-Small-Cell Lung Cancer
    Siva, Shankar
    Callahan, Jason
    MacManus, Michael P.
    Martin, Olga
    Hicks, Rodney J.
    Ball, David L.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (08) : E71 - E72
  • [25] Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer
    Yung, T.
    Giuliani, M. E.
    Le, L. W.
    Sun, A.
    Cho, B. C. J.
    Bezjak, A.
    Brade, A.
    Hope, A. J.
    CURRENT ONCOLOGY, 2012, 19 (04) : E264 - E269
  • [26] Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer
    Hayman, James A.
    Abrahamse, Paul H.
    Lakhani, Indu
    Earle, Craig C.
    Katz, Steven J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04): : 1001 - 1007
  • [27] Optimal radiotherapy for non-small-cell lung cancer: Current progress and future challenges
    Ishikura S.
    General Thoracic and Cardiovascular Surgery, 2012, 60 (3) : 127 - 131
  • [28] Docetaxel (Taxotere®) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer
    Ornstein, DL
    Nervi, AM
    Rigas, JR
    ANNALS OF ONCOLOGY, 1999, 10 : 35 - 40
  • [29] Use of Perfusion SPECT to Preserve Functional Lung in Radiotherapy for Non-Small-Cell Lung Cancer (NSCLC) Patients
    Ramella, S.
    Greco, C.
    Ippolito, E.
    Fiore, M.
    Gentile, S.
    Miele, M.
    D'Angelillo, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S635 - S636
  • [30] Involved-field radiotherapy alone for early-stage non-small-cell lung cancer
    Cheung, PCF
    Mackillop, WJ
    Dixon, P
    Brundage, MD
    Youssef, YM
    Zhou, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 703 - 710